NOVAVAX INC
NOVAVAX INC
Share · US6700024010 · NVAX · A2PKMZ (XNAS)
Overview Financial Indicators
7,01 USD
1,09 % 0,08 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
16.06.2025 18:52

Current Prices from NOVAVAX INC

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
NVAX
USD
16.06.2025 18:52
7,01 USD
6,94 USD
+0,94 %
XFRA: Frankfurt
Frankfurt
NVV1.F
EUR
16.06.2025 17:25
6,05 EUR
6,05 EUR
+0,02 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
1,09 % -5,59 % 11,37 % -12,32 % -23,10 % -51,35 % -86,62 %

Company Profile for NOVAVAX INC Share

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Invested Funds

The following funds have invested in: NOVAVAX INC invested:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
635,24
Percentage (%)
1,49 %
Fund
iShares Edge MSCI USA Momentum Factor UCITS ETF USD (Dist)
Vol. in million
58,56
Percentage (%)
0,45 %
Fund
iShares MSCI USA Momentum Factor ESG UCITS ETF USD (Acc)
Vol. in million
6.742,79
Percentage (%)
0,43 %
Fund
iShares MSCI World Health Care Sector UCITS ETF USD (Dist)
Vol. in million
852,23
Percentage (%)
0,23 %
Fund
iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist)
Vol. in million
594,60
Percentage (%)
0,05 %

Company Data

Name NOVAVAX INC
Company Novavax, Inc.
Symbol NVAX
Website https://www.novavax.com
Primary Exchange XNAS NASDAQ
WKN A2PKMZ
ISIN US6700024010
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. John Charles Jacobs M.B.A.
Market Capitalization 835 Mio
Country United States of America
Currency USD
Employees 1,0 T
Address 21 Firstfield Road, 20878 Gaithersburg
IPO Date 2001-02-01

Stock Splits

Date Split
10.05.2019 1:20

Ticker Symbols

Name Symbol
Frankfurt NVV1.F
NASDAQ NVAX
XETRA NVV1.DE

More Shares

Investors who NOVAVAX INC hold also have the following shares in their portfolio:
AMAZON.CO INC
AMAZON.CO INC Share
APPLE INC
APPLE INC Share
BIONTECH SE ADR
BIONTECH SE ADR Share
CD PROJEKT SA
CD PROJEKT SA Share
M&T BANK CORP
M&T BANK CORP Share
META PLATFORMS INC
META PLATFORMS INC Share
MICROSOFT CORP
MICROSOFT CORP Share
NETFLIX INC
NETFLIX INC Share
NSJ GOLD CORP.
NSJ GOLD CORP. Share
NVIDIA CORP
NVIDIA CORP Share
TESLA INC
TESLA INC Share
VONTOBEL-EO CO.BD M.Y.AEO
VONTOBEL-EO CO.BD M.Y.AEO Fund
WALT DISNEY INC
WALT DISNEY INC Share
YAGEO CORP.GDR144A/5 TA10
YAGEO CORP.GDR144A/5 TA10 Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025